KIAA1614: a candidate link to polarity, still largely uncharacterized
Why it appeared
KIAA1614 had the highest methylation frequency of the three validated promoter-panel genes in the cited UC series, with reduced RNA expression Kang et al..
The underlying evidence came from a small 450K discovery set (8 UC, 3 controls), followed by targeted technical validation in 79 UC samples and bulk qRT-PCR (Kang, Bae, Han, Kim, Kim, and Yi, 2016). “Highest frequency” therefore refers to this selected panel and cohort; it is not a population prevalence estimate or an independently validated clinical sensitivity.
Expressed
Predicted participation in cell polarity, localization, and the centrosome cycle.
→
Expression reduced
A plausible polarity phenotype exists, but it has not been demonstrated in UC epithelium.
Function and loss
NCBI’s curated record lists predicted involvement in centrosome cycle, establishment or maintenance of cell polarity, and regulation of cellular localization, with predicted activity at the apical membrane, cortex, and nucleus. Much of this annotation is computational rather than direct human intestinal evidence.
If genuine loss disrupted epithelial polarity, one could imagine altered apical–basal organization or repair. That is a testable hypothesis, not a result. Lower bulk-tissue RNA could also reflect fewer expressing cells rather than repression within each cell.
Biomarker before mechanism
Near-term work should treat the locus as a candidate classifier: lock the assayed CpGs, test inflammation-matched disease controls, and validate externally. Mechanistic work can proceed in parallel, but predicted Gene Ontology annotations should not be used as evidence that KIAA1614 controls colon polarity.